Optimal Therapeutic Strategy for Ventricular Septal Defect Closure in Extremely Preterm Infants with Chronic Lung

Akari Sato1, Mai Sekine1, Hidenori Kawasaki1

  • 1Department of Pediatrics, Saitama Medical Center, Saitama Medical University.

PubMed

Insights

Pulmonary artery banding followed by VSD closure is a viable strategy for preterm infants with severe congenital heart defects and lung disease. This approach may prevent pulmonary hypertension crises after surgery.

Area of Science:

  • Pediatric Cardiology
  • Neonatology
  • Congenital Heart Surgery

Background:

  • Preterm infants with large ventricular septal defects (VSD), severe chronic lung disease (CLD), and pulmonary hypertension (PH) face hemodynamic instability after open-heart surgery.
  • Clinical decision-making regarding initial pulmonary artery banding versus one-stage VSD closure is challenging due to a lack of established guidelines for this unique population.

Purpose of the Study:

  • To report a successful case of pulmonary artery banding followed by VSD closure in an extremely preterm infant.
  • To review existing literature on managing VSD with CLD and PH in preterm infants.

Main Methods:

  • A case report of a preterm infant (23 weeks 4 days gestation, 540 g) with VSD, CLD, and PH treated with initial pulmonary artery banding and subsequent VSD closure.
  • Literature review of similar cases in preterm infants with VSD, CLD, and PH.

Main Results:

  • The infant successfully underwent pulmonary artery banding and later VSD closure, with pre-banding hemodynamics showing a pulmonary-to-systemic blood flow ratio of 2.5 and pulmonary vascular resistance of 2.6 U·m².
  • Literature search identified five infants (including this case) with VSD, CLD, and PH; one underwent banding first and survived, while three underwent one-stage VSD closure with one mortality due to postoperative PH crisis.
  • Three of the five reviewed infants required tracheostomy.

Conclusions:

  • The choice between initial pulmonary artery banding and one-stage VSD closure requires careful case-by-case evaluation, considering the severity of VSD, CLD, and PH.
  • Further registry studies are necessary to clarify the outcomes of these two surgical strategies in this high-risk population.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
589
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
397
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
287